Pharming Group (PHGUF)
OTHER OTC:PHGUF
Holding PHGUF?
Track your performance easily

Pharming Group (PHGUF) Financial Statements

90 Followers

Pharming Group Financial Overview

Pharming Group's market cap is currently ―. The company's EPS TTM is $-0.025; its P/E ratio is -30.39; Pharming Group is scheduled to report earnings on March 13, 2025, and the estimated EPS forecast is
gt;-0.01. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Dec 22Sep 22Jun 22Mar 22
Income Statement-
Total Revenue--$ 54.24M$ 50.15M$ 46.62M
Gross Profit--$ 51.85M$ 46.12M$ 41.74M
EBIT--$ 10.53M$ 20.91M$ 5.61M
EBITDA--$ 12.48M$ 22.98M$ 7.80M
Net Income Common Stockholders--$ 9.10M$ 15.74M$ 3.46M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 213.42M$ 2.90M$ 188.70M$ 189.96M$ 189.67M
Total Assets$ 462.85M$ 425.80M$ 382.32M$ 393.90M$ 392.80M
Total Debt$ 171.54M$ 166.69M$ 139.18M$ 149.00M$ 157.79M
Net Debt$ -41.88M$ 163.79M$ -49.52M$ -40.96M$ -31.89M
Total Liabilities$ 244.07M$ 242.90M$ 182.07M$ 194.23M$ 198.78M
Stockholders Equity$ 218.78M$ 205.87M$ 200.25M$ 199.67M$ 194.02M
Cash Flow-
Free Cash Flow--$ 12.51M$ 2.81M$ 234.00K
Operating Cash Flow--$ 12.62M$ 4.00M$ 609.00K
Investing Cash Flow--$ -298.00K$ 6.39M$ -374.00K
Financing Cash Flow--$ -1.92M$ -451.00K$ -2.89M
Currency in USD

Pharming Group Earnings and Revenue History

Pharming Group Debt to Assets

Pharming Group Cash Flow

Pharming Group Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis